|
⚲
|
| Keyboard |
| Dalton Barbara
✚
|
|
|---|---|
| CIK # | 0001591318 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591318] | |
| 4 | [0001591318] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dalton Barbara | |
| Enliven Therapeutics Inc | |
| Morphic Holding Inc | |
| Celladon Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enliven Therapeutics Inc IMRA
Stock Options (Right to Buy) · derivative
|
2022-06-02 | Grant | 8,500 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Stock Option (right to buy) · derivative
|
2021-06-29 | Grant | 7,728 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
|
2020-03-16 | Conversion | 5,470,492 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
|
2020-03-16 | Conversion | 478,749 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
|
2020-03-16 | Conversion | 1,894,444 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Stock Option (right to buy) · derivative
|
2020-03-16 | Grant | 15,457 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 1,245,222 |